Development and Validation of a HPLC‐MS/MS Method for the Determination of Compound 13b in Rat Plasma and Its Application to a Pharmacokinetic Study
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Guofang Bi und 11 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-M…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Anthraquinones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Shenzhen Science and Technology Program, Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Compound 13b, a newly identified anthraquinone derivative, has demonstrated potent efficacy against the Zika virus. To explore the bioavailability and pharmacokinetic properties of compound 13b, a robust and sensitive HPLC‐MS/MS method was established and verified to determine its plasma concentration in rats. Sample preparation involved protein precipitation using acetonitrile with testosterone as an internal standard. A Phenomenex Kinetex XB‐C18 column (2.1 × 100 mm, 2.6 μm) was utilized for sample separation with gradient elution. The mobile phase, consisting of water and acetonitrile, was dispensed at a flow rate of 1 mL/min. The multiple reaction monitoring mode (MRM) approach was used to detect compound 13b and testosterone, characterized by their respective ionization transitions: m/z 410.2 → 91.1 and m/z 289.2 → 109.2. The method demonstrated superior linearity within rat plasma samples, ranging from 2 to 400 ng/mL, and met all FDA guidelines for bioanalytical method validation. The pharmacokinetic properties were calculated by non‐compartmental approach following administration of compound 13b at 14 mg/kg in rats, and the absolute oral bioavailability was found to be 15.45%. Hence, a highly sensitive and rapid HPLC‐MS/MS method for measuring plasma concentration of compound 13b in rats has been successfully developed, rigorously validated, and subsequently utilized in a bioavailability and pharmacokinetic study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical…
- Clinical Experimental Center, Jiangmen Engineering Technology Research Center of Clinical Biobank and Translational Research, Jiangmen Central Hospital, Jiangmen, China.
- The State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Shenzhen Graduate School of Peking University, Shenzhen, China.
- School of Chemistry, Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, South China Normal University, Guangzhou, China.
ORCID-Profile: Huichang Bi
Förderung
- Shenzhen Science and Technology Program
- Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program
- Guangdong Basic and Applied Basic Research Foundation
- Science and Technology Innovation Project of Guangdong Medical Products Administration
- Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Bi, G., Yu, Q., Guo, J., Zhang, S., Wang, P., Jiang, X., Wu, C., Hu, S., Yang, X., Fang, J. H., Long, Y., & Bi, H. (2025). Development and Validation of a HPLC‐MS/MS Method for the Determination of Compound 13b in Rat Plasma and Its Application to a Pharmacokinetic Study. Biomedical Chromatography. https://doi.org/10.1002/bmc.70044
Vancouver
Bi G, Yu Q, Guo J, Zhang S, Wang P, Jiang X, et al. Development and Validation of a HPLC‐MS/MS Method for the Determination of Compound 13b in Rat Plasma and Its Application to a Pharmacokinetic Study. Biomedical Chromatography. 2025. doi:10.1002/bmc.70044
BibTeX
@article{Bi2025,
author = {Bi, Guofang and Yu, Qingqing and Guo, Jiayin and Zhang, Shuqing and Wang, Peng and Jiang, Xiaowen and Wu, Chenghua and Hu, Shuang and Yang, Xiao and Fang, Jian-Hong and Long, Yuhua and Bi, Huichang},
title = {Development and Validation of a HPLC‐MS/MS Method for the Determination of Compound 13b in Rat Plasma and Its Application to a Pharmacokinetic Study},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70044}
}
EUVIMED